Table 1.
Number of reports per drug in children
| ATC code | Drug name | Administration | Drug class | Reports (N) |
|---|---|---|---|---|
| R03DC03 | Montelukast | Oral | LTRA | 2210 |
| R03AC02 | Salbutamol | Inhaled | SABA | 947 |
| R03DX05 | Omalizumab | Subcutaneous | Monoclonal antibody | 690 |
| R03CC02 | Salbutamol, systemic | Oral, intravenous | SABA | 676 |
| R03BA02 | Budesonide | Inhaled | ICS | 584 |
| R03AK06 | Salmeterol + fluticasone | Inhaled | LABA + ICS | 565 |
| R03BA05 | Fluticasone | Inhaled | ICS | 391 |
| R03BA01 | Beclomethasone | Inhaled | ICS | 169 |
| R03AK07 | Formoterol + budesonide | Inhaled | LABA + ICS | 161 |
| R03DA04 | Theophylline | Oral, intravenous | Xanthine | 98 |
| R03CC03 | Terbutaline, systemic | Oral, intravenous | SABA | 87 |
| R03BB01 | Ipratropium bromide | Inhaled | SAMA | 85 |
| R03AC13 | Formoterol | Inhaled | LABA | 80 |
| R03AC03 | Terbutaline | Inhaled | SABA | 73 |
| R03BA08 | Ciclesonide | Inhaled | ICS | 36 |
| R03BC01 | Cromoglicic acid | Inhaled | Chromones | 34 |
| R03AC12 | Salmeterol | Inhaled | LABA | 32 |
| R03BA07 | Mometasone | Inhaled | ICS | 31 |
| R03DC01 | Zafirlukast | Oral | LTRA | 29 |
| R03AL01 | Fenoterol and ipratropium bromide | Inhaled | LABA + SAMA | 24 |
| R03AL02 | Salbutamol and ipratropium bromide | Inhaled | SABA + SAMA | 21 |
| R03AK10 | Vilanterol and fluticasone furoate | Inhaled | LABA + ICS | 16 |
| R03BB04 | Tiotropium bromide | Inhaled | LAMA | 9 |
| R03AK11 | Formoterol and fluticasone | Inhaled | LABA + ICS | 3 |
ATC anatomical therapeutic chemical, ICS inhaled corticosteroids, LABA long-acting β-agonist, LAMA long-acting muscarinic antagonist, LTRA leukotriene receptor antagonist, SABA short-acting β-agonist, SAMA short-acting muscarinic antagonist